Literature DB >> 16919237

Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.

Douglas R Hurst1, Alka Mehta, Blake P Moore, Pushkar A Phadke, William J Meehan, Mary Ann Accavitti, Lalita A Shevde, James E Hopper, Yi Xie, Danny R Welch, Rajeev S Samant.   

Abstract

Breast cancer metastasis suppressor 1 (BRMS1) is a member of the mSin3-HDAC transcription co-repressor complex. However, the proteins associated with BRMS1 have not been fully identified. Yeast two-hybrid screen, immuno-affinity chromatography, and co-immunoprecipitation experiments were performed to identify BRMS1 interacting proteins (BIPs). In addition to known core mSin3 transcriptional complex components RBBP1 and mSDS3, BRMS1 interacted with other proteins including three chaperones: DNAJB6 (MRJ), Hsp90, and Hsp70. Hsp90 is a known target of HDAC6 and reversible acetylation is one of the mechanisms that is implicated in regulation of Hsp90 chaperone complex activity. BRMS1 interacted with class II HDACs, HDAC 4, 5, and 6. We further found that BRMS1 is stabilized by Hsp90, and its turnover is proteasome dependent. The stability of BRMS1 protein may be important in maintaining the functional role of BRMS1 in metastasis suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919237      PMCID: PMC1557677          DOI: 10.1016/j.bbrc.2006.08.005

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.

Authors:  S Sif; A J Saurin; A N Imbalzano; R E Kingston
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

2.  Multiple N-CoR complexes contain distinct histone deacetylases.

Authors:  P L Jones; L M Sachs; N Rouse; P A Wade; Y B Shi
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

3.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.

Authors:  M M Saunders; M J Seraj; Z Li; Z Zhou; C R Winter; D R Welch; H J Donahue
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

4.  A multigenic program mediating breast cancer metastasis to bone.

Authors:  Yibin Kang; Peter M Siegel; Weiping Shu; Maria Drobnjak; Sanna M Kakonen; Carlos Cordón-Cardo; Theresa A Guise; Joan Massagué
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

Review 5.  Altered Hsp90 function in cancer: a unique therapeutic opportunity.

Authors:  Rochelle Bagatell; Luke Whitesell
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261

6.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex.

Authors:  Anatoly Y Nikolaev; Nikolaos A Papanikolaou; Muyang Li; Jun Qin; Wei Gu
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

Review 8.  Hsp90: an emerging target for breast cancer therapy.

Authors:  Jason Beliakoff; Luke Whitesell
Journal:  Anticancer Drugs       Date:  2004-08       Impact factor: 2.248

9.  Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription.

Authors:  William J Meehan; Rajeev S Samant; James E Hopper; Michael J Carrozza; Lalita A Shevde; Jerry L Workman; Kristin A Eckert; Michael F Verderame; Danny R Welch
Journal:  J Biol Chem       Date:  2003-10-26       Impact factor: 5.157

10.  Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells.

Authors:  Muzaffer Cicek; Rajeev S Samant; Michael Kinter; Danny R Welch; Graham Casey
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more
  38 in total

1.  Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ.

Authors:  Joel F Andrews; Landon J Sykora; Tiasha Barik Letostak; Mitchell E Menezes; Aparna Mitra; Sailen Barik; Lalita A Shevde; Rajeev S Samant
Journal:  Exp Cell Res       Date:  2012-04-03       Impact factor: 3.905

Review 2.  The epigenetics of breast cancer.

Authors:  Jovana Jovanovic; Jo Anders Rønneberg; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-04-29       Impact factor: 6.603

3.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Authors:  Yekaterina B Khotskaya; Benjamin H Beck; Douglas R Hurst; Zhenbo Han; Weiya Xia; Mien-Chie Hung; Danny R Welch
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

4.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

Review 5.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.

Authors:  Brandon J Metge; Andra R Frost; Judy A King; Donna Lynn Dyess; Danny R Welch; Rajeev S Samant; Lalita A Shevde
Journal:  Clin Exp Metastasis       Date:  2008-06-20       Impact factor: 5.150

7.  Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing.

Authors:  Jie Wang; Andrew Lin; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

8.  The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered.

Authors:  David Pantoja-Uceda; José L Neira; Lellys M Contreras; Christa A Manton; Danny R Welch; Bruno Rizzuti
Journal:  Arch Biochem Biophys       Date:  2019-01-30       Impact factor: 4.013

Review 9.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

10.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.